The role of complement inhibitors in thrombotic microangiopathy with systemic lupus erythematosus

Clin Nephrol. 2024 May;101(5):257-259. doi: 10.5414/CN111279.

Authors

Aliza Anwar Memon, Krista L Lentine, David Brink, Mowaffaq Said

PMID: 38431825
DOI: 10.5414/CN111279

No abstract available

MeSH terms

Complement Inactivating Agents / therapeutic use
Humans
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / drug therapy
Thrombotic Microangiopathies* / drug therapy
Thrombotic Microangiopathies* / etiology

Substances

Complement Inactivating Agents